glp 1 review Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping GLP-1 receptor agonists show promise

Conclusions This study provides a quantitative evaluation of the efficacy and safety of GLP-1RAs and offers valuable insights into the assessment of new drugs for weight reduction

* After subcutaneous administration

By partnering with our weight loss clinic, patients benefit from professional oversight, evidence-based treatments, and ongoing support that can make the journey toward weight loss safer and more effective

Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastroparesis, active pancreatitis, or who are pregnant or planning pregnancy are generally not candidates for GLP-1 therapy

Chen X, Fu J, Zhou F, Yang Q, Wang J, Feng H, et al